Cargando…
AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling
BACKGROUND: Aldo-keto reductase family 1, member B10 (AKR1B10), is known to be significantly induced in the cells of various cancers such as breast cancer. However, the mechanisms of AKR1B10 promoting tumorigenesis in breast cancer remain unclear. In the present study, we demonstrated the potential...
Autores principales: | Li, Jia, Guo, Yuanwei, Duan, Lili, Hu, Xinglin, Zhang, Xi, Hu, Jian, Huang, Li, He, Rongzhang, Hu, Zheng, Luo, Weihao, Tan, Tan, Huang, Renbin, Liao, Duanfang, Zhu, Yuan-Shan, Luo, Di-Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464903/ https://www.ncbi.nlm.nih.gov/pubmed/28402270 http://dx.doi.org/10.18632/oncotarget.16624 |
Ejemplares similares
-
AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway
por: Qu, Jiayao, et al.
Publicado: (2021) -
AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma
por: Liu, Xiangting, et al.
Publicado: (2021) -
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
por: Huang, Li, et al.
Publicado: (2016) -
A novel long non-coding RNA-KAT7 is low expressed in colorectal cancer and acts as a tumor suppressor
por: Wang, Qingmei, et al.
Publicado: (2019) -
The role of long non-coding RNAs in nasopharyngeal carcinoma: As systemic review
por: He, Rongzhang, et al.
Publicado: (2016)